González P, Felip E, Garrido, P, Trigo J, Ortega-Joaquin N, Echave M, Jimenez S, Oyagüez I Cost-effectiveness analysis of nivolumab for the treatment of second-line advanced squamous non-small cell lung cancer (NSCLC) in Spain 19th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Viena, Austria. 29 oct- 2 nov 2016 POSTER
González P, Felip E, Garrido, P, Trigo J, Ortega-Joaquin N, Echave M, Jimenez S, Oyagüez IGonzález P, Felip E, Garrido, P, Trigo J, Ortega-Joaquin N, Echave M, Jimenez S, Oyagüez I